Advertisement

Oversight of National Pharmacies Market Regulations Exercised by the Court of Justice of the European Union

  • Wojciech SzydłoEmail author
Conference paper
Part of the Eurasian Studies in Business and Economics book series (EBES, volume 10/2)

Abstract

The experiences of many EU Member States have demonstrated that the proper functioning of pharmacies is impossible in conditions of total liberalization of regulations governing their establishment. For this reason, in many Member States existing anti-concentration regulations related to the pharmacy market are being continually expanded. The aim of the present paper is to demonstrate, based on conclusions from judgements and rulings issued by the Court of Justice of the European Union, that anti-concentration regulations concerning the pharmacies market are designed to protect effective competition by being functional instruments for achieving the ultimate goals such as: lowered prices of pharmaceuticals and medical products; enhanced availability and diversity of such products in the form of alternatives and substitutes; forcing greater effort to care for the good of consumers in pharmacies, and encouraging activities to boost quality and innovation; reducing the market strength of large enterprises operating in the framework of consortiums (including international capital groups), which frequently apply exclusionary policies detrimental not only to the interests of smaller enterprises, but also of consumers of pharmacies. The analyses will also demonstrate that the introduction of anti-concentration regulations is compatible with the Treaty on the Functioning of the European Union in respect of freedom of enterprise and provision of services. Indeed, the above-mentioned limitations can infringe the right to free trans-border commercial activity and provision of trans-border services contained in Art. 49 and Art. 56 TFEU, but at the same time they are enacted for realization of the so-called imperative requirements in the general interest, for protection of human health and life, and for the safety of patients; additionally, they must meet the test of proportionality in respect to those values.

Keywords

Sectoral regulation Pharmacies market Anti-concentration regulations Court of Justice of the European Union EU freedom to conduct a business EU freedom to provide services 

Notes

Acknowledgment

This publication was prepared within the framework of a research project funded by the National Science Centre according to the decision DEC-2013/08/A/HS5/00642.

References

  1. Berringer, C. (2004). Regulierung als Erscheinungsform der Wirtschaftsaufsicht [Regulation as manifestation of economic supervision]. München: C.H. Beck.Google Scholar
  2. Blair, R., & Sokol, D. (2012). The rule of reason and the goals of antitrust: An economic approach. Antitrust Law Journal, 78, 471–504.Google Scholar
  3. Case C-141/07. (2008). Commission v. Germany. ECR I-6935.Google Scholar
  4. Case C-157/99. (2001). B.S.M. Geraets-Smits v Stichting Ziekenfonds VGZ and H.T.M. Peerbooms v Stichting CZ Groep Zorgverzekeringen. ECR I-5473.Google Scholar
  5. Case C-169/07. (2009) Hartlauer Handelsgesellschaft mbH v Wiener Landesregierung and Oberösterreichische Landesregierung. ECR I-1721.Google Scholar
  6. Case C-170/04. (2007). Klas Rosengren and others v Riksåklagaren. ECR I-4071.Google Scholar
  7. Case C-322/01. (2003). Deutscher Apothekerverband v DocMorris. ECR 2003 I-14887.Google Scholar
  8. Case C-369/88. (1991). Criminal proceedings against Jean-Marie Delattre. ECR I-1487.Google Scholar
  9. Case C-372/04. (2006). Watts v Bedford Primary Care Trust. ECR I-4325.Google Scholar
  10. Case C-531/06. (2009). Commission v Italy. ECR I-4103.Google Scholar
  11. Case C-70/95. (1997). Sodemare SA, Anni Azzurri Holding SpA and Anni Azzurri Rezzato Srl v Regione Lombardia. ECR I-3395.Google Scholar
  12. Directive 2005/36/EC of 7 September 2005 of the European Parliament and the Council on recognition of professional qualifications (2005). OJ L 255/22.Google Scholar
  13. Joined Cases C-171/07 and C-172/07. (2009). Apothekerkammer des Saarlandes and Others (C-171/07) and Helga Neumann-Seiwert (C-172/07) v Saarland and Ministerium für Justiz, Gesundheit und Soziales. ECR I-04171.Google Scholar
  14. Joined Cases C-570/07 and C-571/07. (2010). José Manuel Blanco Pérez, María del Pilar Chao Gómez v Consejería de Salud y Servicios Sanitarios (C-570/07), Principado de Asturias (C-571/07). ECR I-4629.Google Scholar
  15. Justification for the draft bill amending the Pharmaceutical Law, Sejm circular, No. 1126, 2016 [online]. Accessed April 30, 2017, from http://www.sejm.gov.pl/Sejm8.nsf/PrzebiegProc.xsp?nr=1126
  16. Kohutek, K. (2012). Praktyki wykluczające przedsiębiorstw dominujących. Prawidłowość i stosowalność reguł prawa konkurencji [Excluding practices of dominant undertakings. Correctness and applicability of competition law rules]. Warszawa: Wolters Kluwer.Google Scholar
  17. Kühling, J. (2004). Sektorspezifische Regulierung in den Netzwirtschaften. Typologie. Wirtschaftsverwaltungsrecht. Wirtschaftsverfassungsrecht [Sector-specific regulation in the network economies. Typology. Administrative law. Economic Constitutional Law]. München: C.H. Beck.Google Scholar
  18. Motta, M. (2004). Competition policy. Theory and practice. Cambridge: Cambridge University Press.CrossRefGoogle Scholar
  19. Nazzini, R. (2011). The foundations of European Union Competition Law: The objective and principles of article 102. Oxford: Oxford University Press.CrossRefGoogle Scholar
  20. Pharmaceutical Law of 6 September 2001. (2017).Journal of Laws of the Republic of Poland. No. 2211.Google Scholar
  21. Schmidt, I. (2005). Wettbewerbspolitik und Kartellrecht [Competition policy and antitrust law]. Stuttgart: Uni-Taschenbücher.Google Scholar
  22. Skoczny, T. (Ed.). (2009). Ustawa o ochronie konkurencji i konsumentów. Komentarz [The act on the protection of competition and consumers. The commentary]. Warszawa: C.H. Beck.Google Scholar
  23. Szydło, M. (2006). Swobody rynku wewnętrznego a reguły konkurencji. Między konwergencją a dywergencją [The freedoms of the internal market and the rules of competition. Between convergence and divergence]. Toruń: Towarzystwo Naukowe Organizacji i Kierownictwa “Dom Organizatora”.Google Scholar
  24. Szydło, M. (2010a). Nadużycie pozycji dominującej w prawie konkurencji [Abuse of a dominant position in competition law]. Warszawa: Wolters Kluwer.Google Scholar
  25. Szydło, M. (2010b). Prawo konkurencji a regulacja sektorowa [Competition law and sectoral regulation]. Warszawa: Wolters Kluwer.Google Scholar
  26. Szydło, M. (2017). Legal opinion on draft law amending the Pharmaceuticals Act, Sejm circular, No. 1126 [online]. Accessed May 7, 2017, from http://www.sejm.gov.pl/Sejm8.nsf/opinieBAS.xsp?nr=1126

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Faculty of Law, Administration and EconomicsInstitute of Civil Law, University of WrocławWrocławPoland

Personalised recommendations